Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The SMARTEX Heart Failure Study (SMARTEX)

This study has been completed.
Sponsor:
Collaborators:
University Hospital, Antwerp
UMC Utrecht
Technische Universität München
Heartcenter Leipzig GmbH
Bispebjerg Hospital
St. Olavs Hospital
Helse Stavanger HF
Scientific Institute of Veruno
Centre Hospitalier du Luxembourg
Alesund Hospital
Levanger Hospital
Information provided by (Responsible Party):
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00917046
First received: June 8, 2009
Last updated: November 11, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2014
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)